Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.C000413200 on September 5, 2000

J. Biol. Chem., Vol. 275, Issue 42, 32716-32720, October 20, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/42/32716    most recent
C000413200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skiba, N. P.
Right arrow Articles by Arshavsky, V. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skiba, N. P.
Right arrow Articles by Arshavsky, V. Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Effector Enzyme Regulates the Duration of G Protein Signaling in Vertebrate Photoreceptors by Increasing the Affinity between Transducin and RGS Protein*

Nikolai P. Skiba, Johnathan A. Hopp, and Vadim Y. ArshavskyDagger

From the Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston Massachusetts 02114

Received for publication, June 28, 2000, and in revised form, September 1, 2000


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The photoreceptor-specific G protein transducin acts as a molecular switch, stimulating the activity of its downstream effector in its GTP-bound form and inactivating the effector upon GTP hydrolysis. This activity makes the rate of transducin GTPase an essential factor in determining the duration of photoresponse in vertebrate rods and cones. In photoreceptors, the slow intrinsic rate of transducin GTPase is accelerated by the complex of the ninth member of the regulators of G protein signaling family with the long splice variant of type 5 G protein beta subunit (RGS9·Gbeta 5L). However, physiologically rapid GTPase is observed only when transducin forms a complex with its effector, the gamma  subunit of cGMP phosphodiesterase (PDEgamma ). In this study, we addressed the mechanism by which PDEgamma regulates the rate of transducin GTPase. We found that RGS9·Gbeta 5L alone has a significant ability to activate transducin GTPase, but its affinity for transducin is low. PDEgamma acts by enhancing the affinity between activated transducin and RGS9·Gbeta 5L by more than 15-fold, which is evident both from kinetic measurements of transducin GTPase rate and from protein binding assays with immobilized transducin. Furthermore, our data indicate that a single RGS9·Gbeta 5L molecule is capable of accelerating the GTPase activity of ~100 transducin molecules/s. This rate is faster than the rates reported previously for any RGS protein and is sufficient for timely photoreceptor recovery in both rod and cone photoreceptors.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The phototransduction cascade of vertebrate photoreceptor cells is a prototypic G protein-based signal transduction cascade. It is uniquely designed to ensure both a high degree of signal amplification and fast signal termination on the physiological subsecond time scale (reviewed in Refs. 1-3). Vision begins upon light excitation of rhodopsin, which activates many molecules of the photoreceptor-specific G protein, transducin. Activated transducin binds to the inhibitory gamma  subunits of its effector, PDE,1 increasing its catalytic activity; this leads to a decrease in the intracellular cGMP level, the closure of cGMP-gated ion channels of the photoreceptor plasma membrane, and progression of the photoresponse.

Photoresponse termination requires the timely inactivation of PDE, which occurs when GTP bound to transducin is hydrolyzed to GDP and inorganic phosphate by the GTPase activity of transducin. However, the intrinsic rate of transducin GTPase is much slower than the rate of photoresponse recovery. In the photoreceptor, this problem is solved by the action of a powerful mechanism of transducin GTPase acceleration (reviewed in Ref. 4). Intensive studies over the past decade have indicated that this mechanism is based on a cooperative action between two protein components, the RGS9·Gbeta 5L complex (5-7) and the transducin target, PDEgamma (8-10). In vivo experiments with transgenic mice indicate that both components are essential to ensure photoresponse recovery on a physiological time scale (11, 12). It is now established that the primary catalytic role in activation of GTP hydrolysis belongs to the RGS homology domain of RGS9·Gbeta 5L. This domain stabilizes the conformation ("transition state") of the transducin alpha  subunit, which is most favorable for GTP hydrolysis. PDEgamma itself does not activate transducin GTPase but rather enhances the activity of RGS9·Gbeta 5L.

The goal of this study was to elucidate the mechanism by which PDEgamma enhances the activation of transducin GTPase by the RGS9·Gbeta 5L complex. In principle, two possibilities could be considered. First, PDEgamma could directly contribute to GTP hydrolysis, for example, by further stabilizing the Galpha t transition state beyond the action of the RGS domain. Second, it could act by increasing the affinity between activated Galpha t and RGS9·Gbeta 5L. Previous efforts to answer this question using the expressed RGS homology domain of RGS9 yielded contradictory results. McEntaffer et al. (13) reported that PDEgamma acts catalytically by increasing the maximal GTPase rate ~2-fold and that it does not change the apparent affinity between the RGS9 homology domain and transducin. To the contrary, Skiba et al. (14) presented evidence that the entire PDEgamma effect consists of an ~3-fold increase in the affinity between the RGS9 homology domain and transducin. The reason for this incongruity is unknown. Furthermore, it is unclear whether the RGS9 homology domain could serve as a good model for studying the effects of PDEgamma because the degree of transducin GTPase activation by PDEgamma observed with native RGS9·Gbeta 5L within the ROS membranes is at least one order of magnitude higher than the effect observed with the domain alone (10, 9). This finding implies that the physiologically relevant mechanism of PDEgamma action should be addressed with the whole RGS9·Gbeta 5L complex.

In this study, we examined the mechanism by which PDEgamma potentiates the GAP activity of the native RGS9·Gbeta 5L complex in bovine photoreceptor membranes. We used a combination of kinetic analysis and direct binding assays and found that the major effect of PDEgamma on the activation of transducin GTPase is an increase in the affinity between activated transducin and RGS9·Gbeta 5L by >1 order of magnitude. This work provides the first explanation of how an RGS protein and a G protein effector cooperate in regulating the lifetime of G protein in its active state.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Purification of ROS and Various Photoreceptor Membrane Preparations-- ROS were purified from frozen bovine retinas (TA & WL Lawson Co., Lincoln, NE) under infrared illumination as described (15). To obtain membranes lacking most peripheral proteins but retaining an active RGS9·Gbeta 5L complex, ROS were washed under infrared illumination twice with isotonic buffer containing 100 mM KCl, 2 mM MgCl2, 1 mM dithiothreitol and 10 mM Tris-HCl (pH 7.5) and three times by a hypotonic buffer containing 0.5 mM EDTA and 5 mM Tris-HCl (pH 7.5). We will call this preparation "washed membranes" throughout the rest of the text. The amount of residual transducin in "washed membranes" did not exceed 1% of the original endogenous transducin content, as estimated from Coomassie-stained SDS-PAGE gels. Rhodopsin concentration in all membrane preparations was determined spectrophotometrically by measuring the difference in absorbance at 500 nm before and after rhodopsin bleaching (16).

Preparation of Transducin, PDEgamma , and Peptide Encompassing PDEgamma Residues 63-87 (PDEgamma -(63-87))-- Transducin was purified from bovine ROS as described (17). Transducin concentration was first estimated by the Bradford method (18), using bovine serum albumin as the standard, and then the precise concentration of functionally active transducin was measured by the maximal amount of rhodopsin-catalyzed GTPgamma S binding (19). Transducin concentration, as determined with GTPgamma S, was used in all data analyses. Recombinant bovine wild type PDEgamma was expressed in Escherichia coli and purified as described in (20). Peptide corresponding to residues 63-87 of PDEgamma was synthesized and purified as described (10). The purity and chemical formula of PDEgamma -(63-87) were confirmed by mass spectrometry and reversed-phase high pressure liquid chromatography. PDEgamma and PDEgamma -(63-87) concentration was determined spectrophotometrically using a molar extinction coefficient epsilon 280 of 7,100.

Cloning and Expression of Recombinant Galpha t-- Galpha t cDNA, preceded by a nucleotide sequence encoding a hexa-histidine amino acid tag, was cut off pHis6Galpha t (21) with EcoRI and PstI and inserted into the baculovirus transfer vector pVL1393 digested with EcoRI and PstI. The recombinant baculovirus was generated using a BaculoGold transfection kit (PharMingen). The resulting recombinant Galpha t is N-terminally modified with the His6 tag and therefore lacks N-terminal myristoyl moiety. Sf9 cells from a 2-liter shaking culture were collected 72 h post-infection. His6-Galpha t was purified from the cytoplasmic fraction using a combination of affinity chromatography on Ni-NTA-agarose (Qiagen) and anion exchange chromatography on MonoQ (Amersham Pharmacia Biotech) essentially as described for Galpha t/Galpha i1 chimeras (21). The concentration of active Galpha t able to interact with rhodopsin and Gbeta gamma was determined as the maximal amount of rhodopsin/Gbeta gamma -dependent [35S]GTPgamma S binding (19).

GTPase Measurements-- Transducin GTPase activity was determined by using either a multiple-turnover ([GTP] > [transducin]) or single-turnover ([GTP] < [transducin]) technique as described previously (22). GTPase assays were conducted at room temperature (22-24 °C) in a buffer containing 10 mM Tris-HCl (pH 7.8), 100 mM NaCl, 8 mM MgCl2, and 1 mM dithiothreitol. Washed membranes, used as the source of both rhodopsin (to activate transducin) and RGS9·Gbeta 5L, were illuminated on ice immediately before the experiments. The reaction was started by adding 10 µl of [gamma -32P]GTP at the desired concentration (approximately 105 dpm/sample) to 20 µl of washed membranes (30 µM rhodopsin) reconstituted with the proteins of choice. The reaction was stopped by the addition of 100 µl of 6% perchloric acid. 32Pi formation was measured with activated charcoal as described (22). All data fitting and statistical analyses were performed with Sigmaplot software, version 6.

Binding of RGS9·Gbeta 5L Complex to his6-Galpha t Immobilized on Ni-NTA-Agarose-- Washed membranes containing 10 µg of rhodopsin were solubilized in 20 mM Tris-HCl (pH 8.0), 100 mM NaCl, and 1 mM dithiothreitol containing 1% lauryl sucrose (Calbiochem). Insoluble material was removed by a 10-min centrifugation at 120,000 × g with a Beckman Airfuge, and the supernatant was mixed with 10 µl of Ni-NTA-agarose beads pre-bound to ~5 µg of his6-Galpha t in 50 µl of 20 mM Tris-HCl (pH 8.0), 100 mM NaCl, and 0.2% lauryl sucrose. 10 mM NaF, 30 µM AlCl3, and/or 10 µM PDEgamma was added if needed. Samples were incubated on ice for 30 min with occasional shaking. The agarose beads were spun down and washed twice for 5 min with 1 ml of 20 mM Tris-HCl (pH 8.0), 300 mM NaCl, 20 mM imidazole, 0.25% lauryl sucrose, or the same buffer containing 10 mM NaF and 30 µM AlCl3 (for the AlF4-activated samples). Bound RGS9 was eluted from the resin with the SDS-gel sample buffer, subjected to SDS-PAGE (23), and detected by Western blot analysis using specific antibodies and an ECL substrate kit (Amersham Pharmacia Biotech).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The goal of this study was to evaluate the relation between PDEgamma and the native RGS9·Gbeta 5L complex in regulating transducin GTPase. We took advantage of the fact that native RGS9·Gbeta 5L is tightly associated with ROS membranes (6), which enabled us to deplete ROS membranes of endogenous PDE, transducin, and other extractable proteins while preserving their entire RGS9·Gbeta 5L content. Previous studies indicate that a significant cooperation between RGS9·Gbeta 5L and PDEgamma is observed in experiments utilizing this type of washed ROS membrane preparation (10, 9).

The unique feature of studying components of the phototransduction cascade is that the G protein transducin can be supplied by a practically unlimited amount of its activated receptor, bleached rhodopsin. This makes it possible to study the effects of RGS9·Gbeta 5L on transducin GTPase under steady-state conditions in which hydrolysis of Galpha t-bound GTP is followed immediately by recycling of transducin to the GTP-bound form (24). As illustrated in Reaction 1 below, this steady-state situation could be analyzed by the Michaelis analysis, where RGS9·Gbeta 5L is considered the enzyme, Galpha t-GTP the substrate, and Galpha t-GDP and inorganic phosphate the reaction products (the rate of GTPase reaction under these conditions is not dependent on the concentrations of GTP and bleached rhodopsin to the extent that these concentrations are saturating).
<UP>RGS9·G&bgr;5L</UP>+ <UP>G</UP>&agr;<SUB><UP>t</UP></SUB><UP>-GTP</UP> <LIM><OP><ARROW>↔</ARROW></OP><LL>k<SUB>−1</SUB></LL><UL>k<SUB>+1</SUB></UL></LIM> <UP>RGS9 · G&bgr;5L</UP>×<UP>G&agr;<SUB>t</SUB>-GTP</UP> <LIM><OP><ARROW>→</ARROW></OP><UL>k<SUB><UP>cat</UP></SUB></UL></LIM>

<UP>RGS9 · G&bgr;5L</UP>+<UP>G&agr;<SUB>t</SUB>-GDP</UP>+<UP>P<SUB>i</SUB></UP>

<UP><SC>Reaction</SC> 1</UP>
We therefore could assess directly whether PDEgamma influences kcat or apparent Km in this reaction after measuring the rate of the GTPase reaction at a fixed concentration of RGS9·Gbeta 5L and various transducin concentrations. However, before pursuing this analysis we needed to solve two experimental problems outlined below.

First, PDEgamma has been documented to inhibit rhodopsin-dependent transducin recycling from the GDP- to the GTP-bound form (25, 26). This is most likely because the sites of transducin interaction with rhodopsin and PDEgamma overlap, allowing competition between PDEgamma and rhodopsin for binding to transducin (27). As a result, transducin activation is partially blocked (27), making it essentially impossible to know the concentration of Galpha t-GTP in the steady-state Michaelis analysis when PDEgamma is present. We solved this problem by substituting PDEgamma by its C-terminal peptide, PDEgamma -(63-87), which has been shown to represent the GAP activity of PDEgamma (10). This peptide essentially lacks the ability to bind to the GDP-bound form of transducin because a different site on PDEgamma , PDEgamma -(24-45), is responsible for this interaction (21, 27). To confirm that PDEgamma -(63-87) potentiates the GAP activity of RGS9·Gbeta 5L to the same extent as the full-length PDEgamma , we conducted a single-turnover GTPase assay in which only one synchronized turnover of transducin GTPase is allowed and transducin recycling does not take place (Fig. 1). Our data indicate that PDEgamma and PDEgamma -(63-87) cause the same degree of transducin GTPase activation at their saturating concentrations of 1 µM.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 1.   PDEgamma and PDEgamma -(63-87) are equipotent in stimulating transducin GTPase. Time courses of GTP hydrolysis were determined in single-turnover GTPase assays as described under "Experimental Procedures." Washed ROS membranes containing 20 µM rhodopsin were reconstituted with 2 µM transducin in the presence of 1 µM PDEgamma (open circles) or PDEgamma -(63-87) (closed circles). In the control experiment, no PDEgamma or PDEgamma -(63-87) was added (diamonds). The reactions were started by adding 200 nM [gamma -32P]GTP. At indicated times the reactions were quenched with perchloric acid. Curves were fit as single exponents with 100% hydrolysis corresponding to 200 nM GTP. The data represent one of two similar experiments.

Second, we needed to distinguish between the basal transducin GTPase activity and the activity stimulated by RGS9·Gbeta 5L. Because it is not possible to remove RGS9·Gbeta 5L from the washed membranes under nondenaturing conditions, we blocked RGS9·Gbeta 5L activity with specific affinity-purified sheep antibodies derived against a fragment of RGS9 between residues 226 and 484 (5, 7). The data presented in Fig. 2 indicate that treatment of washed membranes with these antibodies blocked the ability of RGS9·Gbeta 5L to activate transducin GTPase both in the presence and absence of PDEgamma -(63-87). The effect was dose-dependent with complete inhibition observed at 500 nM antibodies. The specificity of anti-RGS antibodies to inhibit GTPase activation was confirmed in control experiments in which a total fraction of nonimmune sheep IgG did not affect transducin GTPase activity.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 2.   Anti-RGS9 antibodies block the GAP activity of native membrane-bound RGS9·Gbeta 5L. GTP hydrolysis by transducin (5 µM) was determined in the presence of 20 µM washed ROS membranes and 50 µM [gamma -32P]GTP either with (filled bars) or without (open bars) PDEgamma -(63-87) under multiple-turnover conditions. The reaction mixes were supplemented with different concentrations of sheep anti-RGS9 antibodies (Ab) or total pre-immune sheep IgG as indicated below the bar graph. In the control experiment, anti-RGS9 antibody and IgG were omitted. Reactions were started by the addition of GTP, incubated at room temperature for 20 s, and then quenched with perchloric acid. The data represent one of two similar experiments.

A typical experiment addressing the dependence of transducin GTPase rate on transducin concentration under the steady-state conditions is shown in Fig. 3A. The lower data set represents the basal GTPase activity of transducin obtained after blocking the GAP activity of RGS9·Gbeta 5L with anti-RGS9 antibodies. This basal activity is a linear function of transducin concentration. The other two data sets represent GTPase activity in the presence of active RGS9·Gbeta 5L measured with or without PDEgamma -(63-87). The "accelerated" GTPase activities are re-plotted in Fig. 3B after a point by point subtraction of the basal activity from these data sets (closed symbols). Open symbols on the same graph show the data from an experiment carried out under identical conditions but with another set of protein/membrane preparations. The striking difference between the data obtained with and without PDEgamma -(63-87) is that the data with peptide could be fitted by a hyperbola yielding the average value of apparent Km of ~3.2 µM transducin, whereas the data without peptide do not approach saturation over the range of transducin concentrations used. Note that the Km value in the intact photoreceptor could not be derived from the experiment shown in Fig. 3 because in this experiment most of the substrate (Galpha t-GTP-PDEgamma -(63-87)) is soluble (not shown), whereas in the intact rod, the substrate (Galpha t-GTP-PDE) is membrane-attached because of the isoprenoid modification of the PDE alpha  and beta  subunits (28).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 3.   Catalytic properties of native RGS9·Gbeta 5L complex. The GAP activity of membrane-bound RGS9·Gbeta 5L was determined in multiple-turnover GTPase assay (A). Washed ROS membranes were reconstituted with various amounts of transducin in the presence (circles) or absence (triangles) of PDEgamma -(63-87). In the control experiment, 500 nM anti-RGS9 antibody was added to the reaction mixture to completely block the GAP activity of RGS9·Gbeta 5 (squares). GTPase reactions were initiated by the addition of 150 µM GTP and stopped after a 20-s incubation. The lower curve (squares) was fit with a straight line (k = 0.029 s-1). Two upper curves (triangles and circles) were fit with the sum of a hyperbola (Y = Vmax·X/(Km + X)) and straight line (with the slope of 0.029 s-1 determined from the control with anti-RGS9 antibodies), where Vmax is the rate of GTP hydrolysis at saturation, Km is the apparent Michaelis constant, and X is the transducin concentration. Panel B represents accelerated transducin GTPase only. It was obtained after subtraction of the lower curve fit from panel A from the two upper data sets. The closed symbols and solid lines represent the data from the experiment shown in A, the open symbols and dashed lines represent the data from an experiment carried out under identical conditions but with another set of protein/membrane preparations. In the latter experiment, the data without PDEgamma -(63-87) were obtained in duplicate (error bars represent S.E.). The kinetic parameters of accelerated GTP hydrolysis where as follows: Km = 3 µM, Vmax = 1.15 µM·s-1, R2 = 0.98 () and Km = 3.3 µM, Vmax = 1.2 µM·s-1, R2 = 0.91 (open circle ) with PDEgamma -(63-87); Km = 49 µM, Vmax = 0.92 µM·s-1, R2 = 0.99 (black-triangle) and Km = 94 µM, Vmax = 1.09 µM·s-1, R2 = 0.97 (triangle ). Panel C shows the best hyperbolic fits to the data without PDEgamma -(63-87) from each experiment of panel B (solid and dashed lines) and the fits to these data constrained by the assumption that Km in the presence and absence of PDEgamma -(63-87) is the same and equal to 3.2 µM transducin (dotted lines; see "Results" for the explanation for this analysis). Panel D shows the Lineweaver-Burk plots of the data from panel B.

To emphasize that the rate of GTP hydrolysis did not saturate without PDEgamma -(63-87), we re-plotted the data without peptide from both experiments in Fig. 3C and compared the best hyperbolic fits of these data (same as in Fig. 3B) with the fits forced to the Km value of 3.2 observed with the peptide (dotted lines). Whereas the coefficients of determination (R2) of the best fits were equal to 0.99 and 0.97, the corresponding parameters for the forced fits were only 0.75 and 0.54. Although we were not able to concentrate the components of this reconstituted system sufficiently to obtain a highly reliable determination of both Km and Vmax values in the absence of PDEgamma , the difference in the apparent Km values with and without PDEgamma 63-87 in these experiments was at least 15-fold. Hyperbolic fits of the data obtained without PDEgamma yielded Vmax values within an ~25% range of the values observed with PDEgamma -(63-87); this result should be treated cautiously, however, because only ~30% of the calculated Vmax was achieved at the highest transducin concentrations used. The finding that PDEgamma primarily affects the value of the apparent Km rather than the Vmax is further illustrated in Fig. 3D where the data from Fig. 3B are re-plotted in double-reciprocal coordinates. Thus, we conclude that the major effect of PDEgamma in potentiating the GAP activity of RGS9·Gbeta 5L is to increase the affinity between Galpha t-GTP and RGS9·Gbeta 5L.

Another important parameter calculated from the data presented in Fig. 3B is the kcat value for RGS9·Gbeta 5L observed in the presence of PDEgamma -(63-87). Based on the 1:1640 ± 620 RGS9·Gbeta 5L:rhodopsin ratio measured by He et al. (5) in bovine ROS, we calculated that the RGS9·Gbeta 5L concentration in this experiment was 0.012 ± 0.005 µM, and therefore the average kcat value was equal to 98 ± 40 s-1, which makes RGS9·Gbeta 5L the most efficient RGS protein studied so far.

The next set of experiments illustrated in Fig. 4 provides further proof for our conclusion that PDEgamma serves as an "affinity enhancer" between Galpha t-GTP and RGS9·Gbeta 5L. We monitored the binding of RGS9·Gbeta 5L to the His6-tagged Galpha t-GDP immobilized on the Ni-NTA-agarose in the absence or presence of PDEgamma . Native RGS9·Gbeta 5L was solubilized from washed ROS membranes by the mild, non-ionic detergent lauryl sucrose and incubated with the Ni-NTA-agarose beads in the presence of the same detergent. The beads were rinsed, and bound proteins were extracted with the SDS-PAGE sample buffer (see "Experimental Procedures"). The amount of RGS9·Gbeta 5L in the extract was then detected by immunoblotting with anti-RGS9 antibodies. We chose to use full-length PDEgamma in this experiment because its higher affinity for transducin than the PDEgamma -(63-87) peptide allowed better protein retention upon agarose washes. The leftmost lane shows the amount of RGS9 loaded on the beads. The next two lanes provide a control showing that RGS9·Gbeta 5L did not bind to inactive GDP-bound Galpha t both with and without PDEgamma . As evident from the last two lanes, transducin activation by AlF4-, which mimics the transition state for GTP hydrolysis most favorable for interacting with RGS proteins (29-31), results in RGS9·Gbeta 5L binding to transducin, and significant binding was observed only in the presence of PDEgamma .


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 4.   Binding of RGS9·Gbeta 5L to his6-Galpha t-GDP immobilized on Ni-NTA-agarose. RGS9·Gbeta 5L was solubilized from washed ROS membranes with 1% lauryl sucrose. Approximately 10 ng of RGS9·Gbeta 5L was mixed with 5 µg of his6-Galpha t-GDP bound to 10 µl of agarose beads in 50 µl of 20 mM Tris-HCl (pH 8.0), 300 mM NaCl, 0.25% lauryl sucrose in the presence or absence of AlF4- and PDEgamma , as indicated below the gel picture. Samples were incubated for 30 min on ice. Beads were then washed twice for 5 min with the same buffer containing 20 mM imidazole. RGS9·Gbeta 5L bound to Galpha t was detected by Western blotting using anti-RGS9 antibody. The leftmost lane shows the total amount (~10 ng) of RGS9 added to his6-Galpha t beads. The data represent one of two similar experiments.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The dual requirement for an RGS protein (RGS9·Gbeta 5L) and an effector (PDEgamma ) for the timely inactivation of G protein is a unique feature of the vertebrate phototransduction cascade. It is now established that the major catalytic role in activating transducin GTPase belongs to the RGS homology domain of RGS9 and that PDEgamma acts as a facilitator of RGS activity (5, 14). Although PDEgamma was historically the first identified protein capable of activating G protein GTPase activity (8), its exact role in this process remained unknown. The data reported in this study indicate that PDEgamma acts as an enhancer of the affinity between Galpha t-GTP and RGS9·Gbeta 5L. What remains to be elucidated in the future is whether PDEgamma acts allosterically by optimizing the conformation of Galpha t-GTP switch regions, suggested to bind to the RGS9 homology domain or whether it interacts directly with RGS9·Gbeta 5L.

Our finding that PDEgamma enhances the affinity between Galpha t-GTP and RGS9·Gbeta 5L provides a solid mechanistic basis for our hypothesis of why both RGS9·Gbeta 5L and PDEgamma are needed for timely transducin inactivation in photoreceptor cells (4, 11). We noted that when a rod photoreceptor is hit by a photon of light, it needs to accomplish two nearly opposite tasks. First, it must transduce the signal from excited rhodopsin to PDE with high efficiency. Second, it has to inactivate the whole cascade within a fraction of a second. If transducin were allowed to be discharged by RGS9·Gbeta 5L before it formed a complex with PDE, then some transducin molecules would never activate PDE and signal amplification would be diminished. Therefore, the dependence of GTPase activation on transducin association with PDEgamma ensures both high efficiency of signal transmission between transducin and PDE and timely photoresponse recovery. It is tempting to speculate that similar mechanisms may be utilized in other G protein-based signal transduction cascades to solve the same general problem of preserving both response sensitivity and time resolution.

Another important finding of this study is that the PDEgamma -enhanced activity of RGS9·Gbeta 5L reaches the rate of ~100 s-1, which is at least one order of magnitude higher than most reported rates for various RGS proteins (cf. Refs. 24 and 30). However, this rate is on the same order of magnitude as the ~25 s-1 rate constant reported by Mukhopadhyay and Ross (32) for the RGS4-stimulated GTP hydrolysis by Gq. It is interesting to consider the RGS9·Gbeta 5L kcat value of 100 s-1 in the context of photoresponse recovery kinetics. This number sets the upper limit for the rate of PDE inactivation. It appears to be not only sufficient but even excessive when compared with the ~7 s-1 rate of the recovery from single-photon responses of dark-adapted mammalian rods (33, 34). Although the slowest rate-limiting step in the photoresponse recovery may not be transducin GTPase (35), the rate of 100 s-1 is too high when compared with the quenching rates of any phototransduction step derived from physiological experiments (36). This implies that transducin GTPase in rods does not work at its maximal rate, either because each RGS9·Gbeta 5L has to sequentially stimulate the GTPase activity of several transducin molecules and/or because the concentration of activated transducin remains below saturation for RGS9·Gbeta 5L during the course of the photoresponse.

Remarkably, the GTPase rate of 100 s-1 is in the same range as the photoresponse recovery observed in mammalian cones. For example, the flicker fusion frequency of human cone vision, which reflects the speed of the photoresponse, exceeds 60 s-1 and is ~5-fold higher than in rod vision (37). In this context, Cowan and colleagues (6) reported that bovine cones contain a significantly larger amount of RGS9 than rods and suggested that this difference underlies one of the biochemical mechanisms contributing to faster recovery kinetics of cones. Our finding that RGS9·Gbeta 5L has the potential to stimulate transducin GTPase at the rate of ~100 s-1 provides a strong support for their idea. Higher RGS9·Gbeta 5L concentration in cones should result in a higher rate of transducin GTPase and photoresponse recovery by providing a higher frequency of RGS9·Gbeta 5L encounters with Galpha t-GTP-PDE.

    ACKNOWLEDGEMENTS

We thank Drs. V. I. Govardovskii and P. D. Calvert for critical reading of the manuscript.

    FOOTNOTES

* This work was supported by National Institutes of Health Grant EY-12859 and a grant from the Massachusetts Lions Eye Research Fund (to V. Y. A.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Recipient of the Jules and Doris Stein Professorship from Research to Prevent Blindness Inc. To whom correspondence should be addressed: Howe Laboratory of Ophthalmology, Harvard Medical School/MEEI, 243 Charles St., Boston, MA 02114; Tel.: 617-573-4371; Fax: 617-573-4290; E-mail: vadim_arshavsky@meei.harvard.edu.

Published, JBC Papers in Press, September 5, 2000, DOI 10.1074/jbc.C000413200

    ABBREVIATIONS

The abbreviations used are: PDE, type 6 cyclic nucleotide phosphodiesterase from ROS; ROS, rod outer segments; PDEgamma , the inhibitory gamma  subunit of PDE; RGS9, the ninth member of the regulators of G protein signaling family; Gbeta 5L, the long splice variant of type 5 G protein beta  subunit; Galpha t, alpha subunit of transducin; GAP, GTPase-activating protein; GTPgamma S, guanosine 5'-O-(thiotriphosphate); PAGE, polyacrylamide gel electrophoresis.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Chabre, M., and Deterre, P. (1989) Eur. J. Biochem. 179, 255-266
2. Pugh, E. N., Jr., and Lamb, T. D. (1993) Biochim. Biophys. Acta 1141, 111-149
3. Bownds, M. D., and Arshavsky, V. Y. (1995) Behav. Brain Sci. 18, 415-424
4. Arshavsky, V. Y., and Pugh, E. N., Jr. (1998) Neuron 20, 11-14
5. He, W., Cowan, C. W., and Wensel, T. G. (1998) Neuron 20, 95-102
6. Cowan, C. W., Fariss, R. N., Sokal, I., Palczewski, K., and Wensel, T. G. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 5351-5356
7. Makino, E. R., Handy, J. W., Li, T. S., and Arshavsky, V. Y. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 1947-1952
8. Arshavsky, V. Y., and Bownds, M. D. (1992) Nature 357, 416-417
9. Angleson, J. K., and Wensel, T. G. (1994) J. Biol. Chem. 269, 16290-16296
10. Arshavsky, V. Y., Dumke, C. L., Zhu, Y., Artemyev, N. O., Skiba, N. P., Hamm, H. E., and Bownds, M. D. (1994) J. Biol. Chem. 269, 19882-19887
11. Tsang, S. H., Burns, M. E., Calvert, P. D., Gouras, P., Baylor, D. A., Goff, S. P., and Arshavsky, V. Y. (1998) Science 282, 117-121
12. Chen, C. K., Burns, M. E., He, W., Wensel, T. G., Baylor, D. A., and Simon, M. I. (2000) Nature 403, 557-560
13. McEntaffer, R. L., Natochin, M., and Artemyev, N. O. (1999) Biochemistry 38, 4931-4937
14. Skiba, N. P., Yang, C. S., Huang, T., Bae, H., and Hamm, H. E. (1999) J. Biol. Chem. 274, 8770-8778
15. McDowell, J. H. (1993) Methods Neurosci. 15, 123-130
16. Bownds, D., Gordon-Walker, A., Gaide-Huguenin, A.-C., and Robinson, W. (1971) J. Gen. Physiol. 58, 225-237
17. Ting, T. D., Goldin, S. B., and Ho, Y.-K. (1993) Methods Neurosci. 15, 180-195
18. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254
19. Fung, B. B. K., Hurley, J. B., and Stryer, L. (1981) Proc. Natl. Acad. Sci. U. S. A. 78, 152-156
20. Slepak, V. Z., Artemyev, N. O., Zhu, Y., Dumke, C. L., Sabacan, L., Sondek, J., Hamm, H. E., Bownds, M. D., and Arshavsky, V. Y. (1995) J. Biol. Chem. 270, 14319-14324
21. Skiba, N. P., Bae, H., and Hamm, H. E. (1996) J. Biol. Chem. 271, 413-424
22. Cowan, C. W., Wensel, T. G., and Arshavsky, V. Y. (2000) Methods Enzymol. 315, 524-538
23. Laemmli, U. K. (1970) Nature 277, 680-685
24. Nekrasova, E. R., Berman, D. M., Rustandi, R. R., Hamm, H. E., Gilman, A. G., and Arshavsky, V. Y. (1997) Biochemistry 36, 7638-7643
25. Morrison, D. F., Cunnick, J. M., Oppert, B., and Takemoto, D. J. (1989) J. Biol. Chem. 264, 11671-11681
26. Yamazaki, A., Yamazaki, M., Tsuboi, S., Kishigami, A., Umbarger, K. O., Hutson, L. D., Madland, W. T., and Hayashi, F. (1993) J. Biol. Chem. 268, 8899-8907
27. Artemyev, N. O. (1997) Biochemistry 36, 4188-4193
28. Anant, J. S., Ong, O. C., Xie, H., Clarke, S., O'Brien, P. J., and Fung, B. K. K. (1992) J. Biol. Chem. 267, 687-690
29. Sondek, J., Lambright, D. G., Noel, J. P., Hamm, H. E., and Sigler, P. B. (1994) Nature 372, 276-279
30. Berman, D. M., Kozasa, T., and Gilman, A. G. (1996) J. Biol. Chem. 271, 27209-27212
31. Tesmer, J. J. G., Berman, D. M., Gilman, A. G., and Sprang, S. R. (1997) Cell 89, 251-261
32. Mukhopadhyay, S., and Ross, E. M. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 9539-9544
33. Baylor, D. A., Nunn, B. J., and Schnapf, J. L. (1984) J. Physiol (Lond.) 357, 575-607
34. Chen, J., Makino, C. L., Peachey, N. S., Baylor, D. A., and Simon, M. I. (1995) Science 267, 374-377
35. Pepperberg, D. R., Cornwall, M. C., Kahlert, M., Hofmann, K. P., Jin, J., Jones, G. J., and Ripps, H. (1992) Visual Neurosci. 8, 9-18
36. Lyubarsky, A. L., and Pugh, E. N., Jr. (1996) J. Neurosci. 16, 563-571
37. Ripps, H., and Weale, R. A. (1976) in The Eye (Davson, H., ed), Vol. 2A , pp. 185-217, Academic Press, New York


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
K. A. Martemyanov, C. M. Krispel, P. V. Lishko, M. E. Burns, and V. Y. Arshavsky
Functional comparison of RGS9 splice isoforms in a living cell
PNAS, December 30, 2008; 105(52): 20988 - 20993.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. H. Tsang, M. L. Woodruff, K. M. Janisch, M. C. Cilluffo, D. B. Farber, and G. L. Fain
Removal of phosphorylation sites of {gamma} subunit of phosphodiesterase 6 alters rod light response
J. Physiol., March 1, 2007; 579(2): 303 - 312.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. S. Lobanova, S. Finkelstein, H. Song, S. H. Tsang, C.-K. Chen, M. Sokolov, N. P. Skiba, and V. Y. Arshavsky
Transducin Translocation in Rods Is Triggered by Saturation of the GTPase-Activating Complex
J. Neurosci., January 31, 2007; 27(5): 1151 - 1160.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. L. Makino, X.-H. Wen, N. Michaud, I. V. Peshenko, B. Pawlyk, R. S. Brush, M. Soloviev, X. Liu, M. L. Woodruff, P. D. Calvert, et al.
Effects of Low AIPL1 Expression on Phototransduction in Rods
Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 2185 - 2194.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. H. Tsang, M. L. Woodruff, C.-K. Chen, C. Y. Yamashita, M. C. Cilluffo, A. L. Rao, D. B. Farber, and G. L. Fain
GAP-independent termination of photoreceptor light response by excess gamma subunit of the cGMP-phosphodiesterase.
J. Neurosci., April 26, 2006; 26(17): 4472 - 4480.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. E. Grant, L.-W. Guo, M. M. Vestling, K. A. Martemyanov, V. Y. Arshavsky, and A. E. Ruoho
The N Terminus of GTP{gamma}S-activated Transducin {alpha}-Subunit Interacts with the C Terminus of the cGMP Phosphodiesterase {gamma}-Subunit
J. Biol. Chem., March 10, 2006; 281(10): 6194 - 6202.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Garzon, M. Rodriguez-Munoz, A. Lopez-Fando, and P. Sanchez-Blazquez
Activation of {micro}-Opioid Receptors Transfers Control of G{alpha} Subunits to the Regulator of G-protein Signaling RGS9-2: ROLE IN RECEPTOR DESENSITIZATION
J. Biol. Chem., March 11, 2005; 280(10): 8951 - 8960.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Nakamura, B. Kreutz, S. Tanabe, N. Suzuki, and T. Kozasa
Critical Role of Lysine 204 in Switch I Region of G{alpha}13 for Regulation of p115RhoGEF and Leukemia-Associated RhoGEF
Mol. Pharmacol., October&nbs